-
- 抗原 See all Factor Xa (FXa) 试剂盒
- Factor Xa (FXa) (Activated Coagulation Factor X (FXa))
- 检测方法
- Fluorometric
- 应用范围
- Fluorescence Resonance Energy Transfer Microscopy (FRET)
- 品牌
- SensoLyte®
- 产品特性
- The SensoLyte® Rh110 Factor Xa Assay Kit provides a convenient assay for screening of FXa inhibitors or continuous assay of enzyme activity using a fluorogenic substrate. Upon FXa protease cleavage, this substrate generates the Rh110 (rhodamine 110) fluorophore which has a bright green fluorescence that can be detected at excitation/emission=490 nm/520 nm. The longer-wavelength spectra and higher extinction coefficient of the Rh110 provide greater sensitivity and less interference from other reaction components.
- Top Product
- Discover our top product FXa ELISA Kit
-
Activated Coagulation Factor X (FXa) ELISA Kit
FXa 适用: 人 Colorimetric Sandwich ELISA 0.312 ng/mL - 20 ng/mL Plasma, Serum, Tissue Homogenate
Activated Coagulation Factor X (FXa) ELISA KitFXa 适用: 大鼠 Colorimetric Competition ELISA 15.6 pg/mL - 1000 pg/mL Plasma, Serum, Tissue Homogenate
SensoLyte® 520 Factor Xa Assay KitFRET Fluorometric
-
- 说明
-
FRET-based Assay Kit
- 限制
- 仅限研究用
-
- 注意事项
- Protect Components A and B from light and moisture.
- 储存条件
- -80 °C
- 储存方法
- Store all kit components at -20 °C, except for Component C. Store Component C at -80 °C. Component D can be stored at room temperature for convenience
-
- 抗原
- Factor Xa (FXa) (Activated Coagulation Factor X (FXa))
- 别名
- Factor Xa (FXa 产品)
- 别名
- FX Kit, FXA Kit, coagulation factor X Kit, F10 Kit
- 背景
- Factor Xa (FXa) is a serine endopeptidase composed of two disulfide-linked subunits. FXa leads to blood clot formation by converting prothrombin to thrombin through the prothrombinase complex. FXa is generated from zymogen Factor X via the intrinsic and extrinsic pathways and is the rate-limiting step in the propagation of thrombin generation. In the presence of Ca2+ ions, FXa forms prothrombinase with factor Va on the phospholipid membrane of the activated platelets. FXa has emerged as an attractive target for drug discovery for thromboembolic diseases.
-
You are here:
